Netflix has increased urgency to roll out ads, says JPMorgan 07:23 NFLX Netflix shares have traded down 70% year-to-date and investor sentiment remains broadly cautious, JPMorgan analyst Doug Anmuth tells investors in a research note. The analyst believes Netflix has increased urgency around an advertising rollout, which he says "appears to be accelerated to later this year." However, the company has also cautioned that its ad efforts will be iterative over time and the day one launch will not look like the product 6-12 months out, Anmuth points out. He believes Netflix will also try to time the rollout of the ad-supported tier with elevated account sharing efforts. Tightening up around even some of the 100M account sharers globally could be effectively viewed as a price increase, says Anmuth. The analyst, who adds that download trend data is weakening through June, keeps a Neutral rating on Netflix with a $230 price target.
A pos garbage stock that will move up pre-market and then drop. Want a short term winner? Short WOLF right now at $63 with a $65.70 stop. Target $57 EDIT: Actually, wait for the bell and see if you can get in short north of $64.
Idea- FIGS Figs initiated with a Strong Buy at Raymond James 16:54 FIGS Raymond James analyst Rick Patel initiated coverage of Figs with a Strong Buy rating and $15 price target as part of a broader sector note initiating coverage of Digital Commerce. The company has created a "better mousetrap" in the $12B U.S. Healthcare apparel market, the analyst tells investors in a research note, adding that he also sees it as an attractive market segment as jobs in the U.S. Healthcare market are poised to grow 15% from 2019-2029. Patel further notes that he sees the potential for FIGS to stretch beyond its core scrub assortment with total addressable market expansion via lifestyle product, industries outside of Healthcare, and International expansion. Huge amount of healthcare workers in the system coming up. As needed! They need funky scrubs! FIGS-$8.30
I don't think I want to get the Children into shorts now. You see the portfolio it has gravitas. Adding a bunch of shorts to it would seem a silly exercise. We can start a different thread of negativity. I prefer to look on the bright side of life.
I gave you this winner last week at $70.50, I'd stick with it for now. You missed the big move though, its $76. Even the Duke is up to $106 Amazing I know. What can I say? NEE ----> $76 It'll drop today though. Get in below $74
DA Davidson starts Amkor Technology at Buy amid industry strength, capacity ramp 17:25 AMKR DA Davidson analyst Thomas Diffely initiated coverage of Amkor Technology with a Buy rating and $30 price target. The company is the only major OSAT with scale that is not based in China and Taiwan, the analyst tells investors in a research note. Diffely adds that he is positive on the projected industry strength with robust wafer fab equipment and ramping capacities in Advanced Packaging. The analyst further note that Amkor Technology shares are trading at an "attractive" valuation of 6.4-times his 2022 EPS estimate. IDEA #2 AMKR- $16.75 ABB- $26.75/ This has finally fallen from $28-$33 where it lives. Using $33-$36 as a High side target @ $26 ABB is atractive to me. Idea #3 ABB
Well the bright side of life is costing you 25% haircuts. Where I'm from the bright side of (trading) life comes from taking money from WS. Long/short/whatever.
I looked at ABB, it's the whole European recession thing bringing it down. Dead money for now unfortunately.